[1] Hill C J, Cardwell C R, Maxwell A P, et al. Obesity and kidney disease in type 1 and 2 diabetes: an analysis of the National Diabetes Audit[J]. QJM, 2013. 106(10): 933
[2] Bergman R N, Stefanovski D, Buchanan T A, et al. A better index of body adiposity[J]. Obesity, 2011, 19(5): 1083
[3] Garcia A I, Nino-Silva L A, Gonzalez-Ruiz K, et al. Body adiposity index as marker of obesity and cardiovascular risk in adults from Bogota, Colombia[J]. Endocrinol Nutr, 2015, 62(3): 130
[4] Alvim R O, Mourao-Junior C A, de Oliveira C M, et al. Body mass index, waist circumference, body adiposity index, and risk for type 2 diabetes in two populations in Brazil: general and Amerindian[J]. PLoS One, 2014, 9(6): e100223
[5] Moliner-Urdiales D, Artero E G, Sui X, et al. Body adiposity index and incident hypertension: the Aerobics Center Longitudinal Study[J]. Nutr Metab Cardiovasc Dis, 2014, 24(9): 969
[6] Chan J M, Rimm E B, Colditz G A, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men[J]. Diabetes Care, 1994,17(9): 961
[7] Hou X, Lu J, Weng J, et al. Impact of waist circumference and body mass index on risk of cardiometabolic disorder and cardiovascular disease in Chinese adults: a national diabetes and metabolic disorders survey[J]. PLoS One, 2013, 8(3): e57319
[8] 中华医学会内分泌学分会肥胖学组. 中国成人肥胖症防治专家共识[J]. 中华内分泌代谢杂志, 2011, 27(9): 711
[9] Chalmers L, Kaskel F J, Bamgbola O. The role of obesity and its bioclinical correlates in the progression of chronic kidney disease[J]. Adv Chronic Kidney Dis, 2006, 13(4): 352
[10] Lu B, Gong W, Yang Z, et al. An evaluation of the diabetic kidney disease definition in chinese patients diagnosed with type 2 diabetes mellitus[J]. J Int Med Res, 2009,37(5): 1493
[11] Mohsen A, Brown R, Hoefield R, et al. Body mass index has no effect on rate of progression of chronic kidney disease in subjects with type 2 diabetes mellitus[J]. J Nephrol, 2012, 25(3): 384
[12] Garvey W T, Garber A J, Mechanick J I, et al. American association of clinical endocrinologists and american college of endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease[J]. Endocr Pract, 2014, 20(9): 977
[13] Gallagher D, Heymsfield SB, Heo M, et al. Healthy percentage body fat ranges: an approach for developing guidelines based on body mass index[J]. Am J Clin Nutr. 2000. 72(3): 694-701.
[14] Kragelund C, Omland T. A farewell to body-mass index[J]. Lancet. 2005. 366(9497): 1589-1591.
[15] Godoy-Matos A F, Moreira R O, Valerio C M, et al. A new method for body fat evaluation, body adiposity index, is useful in women with familial partial lipodystrophy[J]. Obesity, 2012, 20(2): 440
[16] Djibo D A, Araneta M R, Kritz-Silverstein D, et al. Body adiposity index as a risk factor for the metabolic syndrome in postmenopausal Caucasian, African American, and Filipina women[J]. Diabetes Metab Syndr, 2015, 9(2): 108
[17] Silva M I, Vale B S, Lemos C C, et al. Body adiposity index assess body fat with high accuracy in nondialyzed chronic kidney disease patients[J]. Obesity, 2013, 21(3): 546
[18] Martinez-Garcia C, Izquierdo-Lahuerta A, Vivas Y, et al. Renal lipotoxicity-associated inflammation and insulin resistance affects actin cytoskeleton organization in podocytes[J]. PLoS One, 2015, 10(11): e0142291
[19] Bobulescu I A, Lotan Y, Zhang J, et al. Triglycerides in the human kidney cortex: relationship with body size[J]. PLoS One, 2014, 9(8): e101285
[20] Ejerblad E, Fored C M, Lindblad P, et al. Obesity and risk for chronic renal failure[J]. J Am Soc Nephrol, 2006,17(6): 1695
[21] Morales E, Valero M A, Leon M, et al. Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies[J]. Am J Kidney Dis, 2003, 41(2): 319
[22] Praga M, Morales E. Obesity-related renal damage: changing diet to avoid progression[J]. Kidney Int, 2010,78(7): 633
[23] Zhao D, Li Y, Zheng L, et al. Brief communication: Body mass index, body adiposity index, and percent body fat in Asians[J]. Am J Phys Anthropol, 2013, 152(2): 294
[24] Yu Y, Wang L, Liu H, et al. Body mass index and waist circumference rather than body adiposity index are better surrogates for body adiposity in a chinese population[J]. Nutr Clin Pract, 2015,30(2): 274
[25] Zhang Z Q, Liu Y H, Xu Y, et al. The validity of the body adiposity index in predicting percentage body fat and cardiovascular risk factors among Chinese[J]. Clin Endocrinol, 2014, 81(3): 356
[1]王树峰,杨 丽,刘 寅.脂蛋白相关磷脂酶A2与冠心病和2型糖尿病的关系[J].天津医科大学学报,2013,19(06):456.
WANG Shu-feng,YANG Li,LIU Yin.Relationship between lipoprotein-associated phospholipase A2 and coronary heart disease as well as type 2 diabetes mellitus[J].Journal of Tianjin Medical University,2013,19(03):456.
[2]苏东峰,聂秀玲,孙丽荣.2型糖尿病合并高尿酸血症临床特征及相关危险因素分析[J].天津医科大学学报,2013,19(06):481.
[3]武 鑫,李明珍,孙丽荣.2型糖尿病患者血清γ-谷氨酰转移酶与胰岛β细胞功能的关系[J].天津医科大学学报,2014,20(02):147.
WU Xin,LI Ming-zhen,SUN Li-rong.Association of serum gamma-glutamyltransferase with islet β cell function in type 2 diabetic patients[J].Journal of Tianjin Medical University,2014,20(03):147.
[4]刘 芳,李明珍,孙丽荣.住院2型糖尿病患者睡眠质量与血糖及并发症的关系[J].天津医科大学学报,2014,20(03):213.
LIU Fang,LI Ming-zhen,SUN Li-rong.Relationship between sleep quality and glucose level as well as diabetic complications in hospital patients with type 2 diabetes mellitus[J].Journal of Tianjin Medical University,2014,20(03):213.
[5]李凤英,朱铁虹.中年男性2型糖尿病患者促甲状腺激素与尿钙/肌酐比值的相关性研究[J].天津医科大学学报,2014,20(05):389.
LI Feng-ying,ZHU Tie-hong.Relationship between thyroid stimulating hormone and urinary calcium/creatinine excretion in middle-aged man with type 2 diabetes[J].Journal of Tianjin Medical University,2014,20(03):389.
[6]谭艳萍,吴校伟,刘 寅,等. 冠心病合并糖尿病患者药物涂层支架术后观察[J].天津医科大学学报,2014,20(05):414.
[7]陈河清,郭秀梅,金力里.2型糖尿病患者牙周病与糖尿病肾病的相关性分析[J].天津医科大学学报,2014,20(06):469.
CHEN He-qing,GUO Xiu-mei,JIN Li-li. Correlation between diabetic nephropathy and periodontal disease[J].Journal of Tianjin Medical University,2014,20(03):469.
[8]马 静,赵立华,谢 云.血浆纤维蛋白原与糖尿病肾病的相关性研究[J].天津医科大学学报,2015,21(03):60.
Ma Jing,ZHAO Li-hua,XIE Yun.Relationship between plasma fibrinogen concentration and diabetic nephropathy [J].Journal of Tianjin Medical University,2015,21(03):60.
[9]马 静,赵立华,谢 云. 血浆纤维蛋白原与糖尿病肾病的相关性研究[J].天津医科大学学报,2015,21(01):60.
MA Jing,ZHAO Li-hua,XIE Yun.Relationship between plasma fibrinogen concentration and diabetic nephropathy[J].Journal of Tianjin Medical University,2015,21(03):60.
[10]李 冰,冯 凭.罗格列酮干预糖尿病大鼠脂肪组织CMKLR1及Chemerin基因表达[J].天津医科大学学报,2015,21(06):484.
LI Bing,FENG Ping.Effect of rosiglitazone on the expression of CMKLR1 and Chemerin mRNA in the adipose tissue of diabetic rat[J].Journal of Tianjin Medical University,2015,21(03):484.
作者简介 姚旻(1979-),女,主治医师,博士在读,研究方向:糖尿病及其慢性并发症的发病机制研究;通信作者:张宏,E-mail:zh80008@163.com。